Get started
Work

A Phase II trial of vinorelbine tartrate in patients with disseminated malignant melanoma and one prior systemic therapy

Year: 2004
Type: article
Study design: Clinical Trial
Source: Cancer
DOI: 10.1002/cncr.20183
Authors: Robert P. Whitehead, James Moon, S. Spence McCachren, Evan M. Hersh, Wolfram E. Samlowski, J. Thaddeus Beck, Nerses S. Tchekmedyian, Vernon K. Sondak
Institutions: The University of Texas Medical Branch at Galveston, Thompson Cancer Survival Center, University of Arizona Cancer Center, University of Utah, University of Arkansas for Medical Sciences, University of California, Los Angeles, University of Michigan, Michigan Medicine
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: closed
Awards: G117886320, G1202672505, G1205502904, UCLA/JCCC--SOUTHWEST ONCOLOGY GROUP, G1794831901, G1911575068, G1958973285, G20028727, G2064543036, G268786457, SOUTHWEST ONCOLOGY GROUP STATISTICAL CENTER, G3350348941, G4094841028, Southwest Oncology Group, G5504618518, SOUTHWEST ONCOLOGY GROUP CA13612, Santa Rosa Memorial Hospital Regional CCOP, G6109875642, Southwest Oncology Group Treatment Grant, SOUTHWEST ONCOLOGY GROUP, University of Colorado Southwest Oncology Group, G712978930, CENTRAL ILLINOIS COMMUNITY CLINICAL ONCOLOGY PROGRAM, Community Clinical Oncology Program, G763325562, Kansas City Clincal Oncology Program CCOP, SOUTHWEST ONCOLOGY GROUP (UTAH), G869916006, SOUTHWEST ONCOLOGY GROUP, Montana Cancer Consortium CCOP, Southwest Oncology Group/University of California, Davis
OpenAlex ID: W1512372445
FWCI: 0.32
Cites: 26
Cited by: 24
Related to: 10